Being Alive Newsletter, Being Alive/Los Angeles - October 1992
Mark Katz MD and reported by Jim Stoecker
Certainly, in the early years of the epidemic, many women's HIV disease remained undetected, since they were not thought to be at risk. In addition, proportionately more women than men were drug users whose health was compromised by other conditions. Finally, in the early years, infected women had less access to health care than infected men. All of these are possible explanations for the difference in median survival.
The study also looked at the median survival of those on antiviral therapy (AZT or ddI). For women on antivirals, median survival was 19 months. If not on antivirals, median survival for women dropped to 6 months. For men, median survival was 21.8 months on antivirals vs 14 months if not using antivirals. This seems to support the belief that antiviral therapy prolongs survival. Further, the study data shows that for women and men on antivirals, the difference in median survival is no longer statistically significant (19 months vs 21.8 months). This seems to say that, given equal access to care, equal access to information and available options, there may be no difference between the survival of men and of women.
921001
BA921002
Copyright © 1992 - Beings Alive. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used. Subscription lists are kept confidential. Being Alive, 621 N. San Vicente Blvd., West Hollywood, CA 90069, Tel - 310.289.2551; FAX - 310.289.9866; Email: BeiAlive@aol.com http://www.beingalivela.org/